CV Lattes
ORCID
Abstract
Immunotherapy has revolutionized cancer treatment in recent years, particularly adoptive cell therapy using chimeric antigen receptor (CAR) T cells for hematological tumors. However, for solid tumors, there are several ongoing preclinical and clinical studies showing a challenging scenario due to the lack of expansion and persistence of CAR T cells in vivo, difficulty in migration within …